Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Symptomatic Hypogonadism”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)Study completedNCT01873989
What this trial is testing

Testosterone Replacement for Male Opioid Agonist Maintained Patients

Who this might be right for
Chronic PainOpioid AddictionSymptomatic Hypogonadism
Yale University 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07500766
What this trial is testing

Clinical Evaluation of Subcutaneous Testosterone Implants in Men With Symptomatic Hypogonadism

Who this might be right for
Male HypogonadismTestosterone DeficiencyTestosterone Replacement Therapy+1 more
University of Sao Paulo 30
Post-approval studies (Phase 4)WithdrawnNCT00710827
What this trial is testing

Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks

Who this might be right for
Hypogonadism
Bayer
Testing effectiveness (Phase 2)Study completedNCT00434824
What this trial is testing

Effects of Andriol Testocaps in Symptomatic Late-Onset Hypogonadism (43203)

Who this might be right for
HypogonadismAndrogens
Merck Sharp & Dohme LLC 322
Post-approval studies (Phase 4)Ended earlyNCT01092858
What this trial is testing

NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)

Who this might be right for
Hypogonadism
Bayer 4